Category In The News
These studies provide a foundational rationale for ABC2's efforts in the profiling space.
An ABC2-funded brain cancer vaccine receives positive reviews at the American Society of Clinical Oncology annual meeting.
Our deepest sympathies go out to his friends and family.
We welcome the newest member of our team. Kathleen brings a wealth of major and corporate gift development experience.
ABC2 was an early investor in this pioneering research.
Proceeds from the Florida Brain Cancer 5k support this ongoing partnership.
ABC2 is working with Matt de Silva, co-founder of Notable Labs, to advance personalized treatments for brain cancer.
ABC2 is funding the whole exome sequencing of NeoVax tumors at the Broad Institute to assist Dana-Farber researchers.